SITC Cancer Immunotherapy CONNECT

Welcome to the Society for Immunotherapy of Cancer.

Our mission is to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.

Don't miss us in National Harbor, MD for SITC 2025, our 40^th Anniversary Annual Meeting & Pre-Conference Programs. Visit our SITC 2025 site for the latest information on abstracts, registration, and more.

Visit the SITC 2025 Site

Visit the 2024 Year in Review Website

Discover the host of accomplishments from the past year.

Explore SITC’s six strategic goals, the #SITCQuestfor100 initiative, honors and awards and more, all in support of SITC's mission to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy.

Take me to the website >

Learn from clinical experts with the 2025 Advances in Cancer Immunotherapy (ACI) Series

ACI programs are certified for CME credits and are free for healthcare professionals, students, patients and patient advocates.

Join our third session - A Focus on Bladder & Genitourinary Cancers - starts April 7. New focus points for this year include a discussion of immune checkpoint inhibitor rechallenge for management of bladder and genitourinary cancers.

Learn More >

SITC Statement on NIH Cuts to Indirect Costs

Read the Statement

Browse our other events

A Deep Dive into What's Next for TIL or Adoptive Cell Therapy After the Iovance Approval?

March 26 | 12–2 p.m. ET | Virtual

This webinar will discuss the state of TIL therapy, the biology of TIL therapy, current approaches to develop the next generation of TIL therapies, and considerations when implementing TIL therapy in the clinic.

Advanced Biomarker Development and Clinical Translation: Computational Science in Immuno-oncology

April 2, 2025 | 2–3:30 p.m. ET | Virtual

This webinar will address advances that allow for interpretation of exploratory biomarker data, when most studies are typically only powered for clinical endpoints.

2025 ACI: A Focus on Bladder & Genitourinary Cancers

April 7, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Discuss immune checkpoint inhibitor rechallenge for management of bladder and genitourinary cancers. Gain in-depth clinical education from leading experts!

2025 ACI: A Focus on Gastrointestinal Cancers

April 23, 2025 | 1–5 p.m. EDT | Virtual

Discuss recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers. Improve patient outcomes with cutting-edge insights from clinical experts!

Lunit Research Program

Exclusively for SITC Members | Applications due April 30

This Lunit research program aims to enhance studies led by SITC members by enabling the use of AI for TME profiling, including quantitative immune phenotyping (IP) via three IP classification: inflamed, excluded and desert.

Learn more

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines!

2025 ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies

June 27, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies.

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

Upcoming SITC Events

Monday

24

March

Immuno-Oncology 360°

Mar 24 - 26, (ET)

Boston, MA, United States
Wednesday

26

March

A Deep Dive into What’s Next for TIL or Adoptive Cell Therapy After the Iovance Approval

Mar 26, 12:00 - 14:00 (ET)
Thursday

27

March

Biotech Virtual Program: Research and Development Career Path

Mar 27, 15:00 - 16:00 (CT)
Wednesday

2

April

Advanced Biomarker Development and Clinical Translation: Computational Science in Immuno-oncology

Apr 2, 14:00 - 15:30 (ET)
Monday

7

April

2025 ACI: A Focus on Bladder & Genitourinary Cancers

Apr 7, 11:00 - 15:00 (ET)

Explore More Events

Read the Latest SITC News

SITC Publishes Second Manuscript in JITC Special Series on the Current Challenges and Opportunities in Cancer Immunotherapy

posted 5 hours ago

On behalf of SITC, we are pleased to announce the publication of a new manuscript titled, “ ...

JITC Digest March 2025

posted 5 days ago

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...